Climb Bio (CLYM) vs Faeth Therapeutics (FTH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Climb Bio (CLYM) has outperformed Faeth Therapeutics (FTH) over the past year, gaining 549.1% versus a gain of 121.4%. Over five years, CLYM leads with a -33.6% price change compared with -83.7% for FTH. Faeth Therapeutics is the larger company by market cap ($643.9 million vs $615.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLYM | FTH |
|---|---|---|
| Share price | $10.71 | $24.92 |
| Market cap | $615.14M | $643.94M |
| 1-day change | +0.28% | -7.33% |
| YTD return | +167.75% | +133.55% |
| 1-year return | +549.09% | +121.39% |
| 5-year return | -33.64% | -83.67% |
| EPS (TTM) | $-0.82 | $-60.86 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $18.33 | $42.14 |
| 52-week low | $1.64 | $7.45 |
| Distance from 52-week high | -41.57% | -40.87% |
| Average volume | 1.39M | 348.41K |
| Shares outstanding | 57.44M | 25.84M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CLYM has outperformed FTH by 427.7 percentage points over the past year.
CLYM vs FTH FAQ
Which is bigger, Climb Bio or Faeth Therapeutics?
Faeth Therapeutics (FTH) is larger, with a market capitalization of $643.94M compared with $615.14M for Climb Bio (CLYM).
Which stock has performed better over the past year, CLYM or FTH?
CLYM returned +549.09% over the past 12 months, compared with +121.39% for FTH (price return, excluding dividends). Past performance does not predict future results.
Are Climb Bio and Faeth Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.